一步法筛查妊娠期糖尿病与围产期结局的关联
在Kaiser Permanente Washington医疗计划中开展前后对照队列研究,比较指南由两步法改为一步法筛查妊娠期糖尿病前后的围产期结局。内部就诊孕妇一步法使用率达87%,校正背景趋势后,指南变更与妊娠期糖尿病、引产、新生儿低血糖及无应激试验增加相关,剖宫产和巨大儿无关联。
要点
- 指南变更后内部就诊孕妇一步法使用率达87%,胰岛素使用从1.2%升至4.4%。
- 校正背景趋势后,指南变更与妊娠期糖尿病风险增加相关(RR 1.41,95%CI 1.17-1.69)。
- 引产(RR 1.20)、新生儿低血糖(RR 1.77)和无应激试验(RR 1.12)风险亦增加,剖宫产和巨大儿无关联。
核心结论
- 采用一步法筛查与妊娠期糖尿病诊断增加41%相关,但未改善母婴结局。
研究设计与样本
- 在Kaiser Permanente Washington(华盛顿州混合模式健康计划)开展的前后对照队列研究,纳入单胎活产分娩孕妇。
- 内部就诊孕妇指南变更前(2009年1月至2011年3月)n=4,977,变更后(2012年4月至2014年12月)n=6,337。
- 外部就诊孕妇(未受指南变更影响)变更前n=3,386,变更后n=4,454,用于控制与指南变更无关的时间趋势。
- 使用Poisson广义估计方程估计校正相对危险度(RR)及95%CI。
主要发现
- 指南变更后,内部就诊孕妇中一步法使用广泛达87%,胰岛素使用从1.2%增加3.7倍至4.4%。
- 内部就诊孕妇中,妊娠期糖尿病从6.9%升至11.4%,引产从25.2%升至28.6%,新生儿低血糖从1.3%升至2.0%,门诊无应激试验从每100名孕妇134.6测试日升至157.0测试日。
- 校正背景趋势后,指南变更与妊娠期糖尿病风险增加相关(RR 1.41,95%CI 1.17-1.69)。
- 校正背景趋势后,指南变更与引产风险增加相关(RR 1.20,95%CI 1.09-1.32)。
- 校正背景趋势后,指南变更与新生儿低血糖风险增加相关(RR 1.77,95%CI 1.14-2.75),与无应激试验增加相关(RR 1.12,95%CI 1.02-1.24每100名孕妇)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare perinatal outcomes before and after a clinical guideline change from a two-step to a one-step approach to screening for gestational diabetes mellitus (GDM). METHODS: We conducted a before-after cohort study of women with singleton live birth deliveries within Kaiser Permanente Washington, a mixed-model health plan in Washington state. We used Kaiser Permanente Washington electronic health data and linked birth certificates. We compared outcomes before (January 2009-March 2011) and after (April 2012-December 2014) the guideline change among women who received prenatal care from health care providers internal to Kaiser Permanente Washington (n=4,977 before, n=6,337 after). We made the same comparison among women who received prenatal care from external health care providers (not exposed to the guideline change; n=3,386 before, n=4,454 after) to control for time trends unrelated to the guideline change. Adjusted relative risks and 95% CIs were estimated using Poisson generalized estimating equations. RESULTS: After the guideline change, receipt of the one-step approach became widespread among women cared for by Kaiser Permanente Washington internal providers (87%), and use of insulin increased 3.7-fold from 1.2% to 4.4%. Among women cared for by Kaiser Permanente Washington internal providers, GDM increased from 6.9% to 11.4%, induction of labor from 25.2% to 28.6%, neonatal hypoglycemia from 1.3% to 2.0%, and outpatient nonstress testing from 134.6 to 157.0 test days per 100 women. After accounting for background trends in outcomes (based on the women cared for by external providers), the guideline change was associated with increased incidence of GDM (relative risk [RR] 1.41, 95% CI 1.17-1.69), labor induction (RR 1.20, 95% CI 1.09-1.32), neonatal hypoglycemia (RR 1.77, 95% CI 1.14-2.75), and nonstress testing (RR 1.12, 95% CI 1.02-1.24% per 100 women). There was no association with other outcomes including cesarean delivery or macrosomia. CONCLUSION: Adopting the one-step approach was associated with a 41% increase in the diagnosis of GDM without improved maternal or neonatal outcomes.
引用
- Pocobelli G, Yu O, Fuller S, et al. One-Step Approach to Identifying Gestational Diabetes Mellitus: Association With Perinatal Outcomes. Obstet Gynecol. 2018. PMID: 30130344. doi:10.1097/AOG.0000000000002780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。